{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:09:06Z","timestamp":1772600946107,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sexually transmitted infections (STIs) are a significant global public health issue that cause a high burden of disease, especially in low- and middle-income countries. Screening of key populations and early and accurate diagnosis of infection are critical. Testing for syphilis, <jats:italic>Chlamydia trachomatis<\/jats:italic>, <jats:italic>Neisseria gonorrhoeae<\/jats:italic>, <jats:italic>Trichomonas vaginalis<\/jats:italic>, curable STIs, as well as the human papillomavirus (HPV), is frequently unavailable in low-resource settings. Tests for these STIs that can be used at the point of patient care (POCTs) are needed.<\/jats:p>\n                <jats:p>In recent years, there has been increased attention for STI POCTs, but technical guidance, financial resources and advocacy for additional platforms\/tests are required in order to foster the development of STI POCTs. The WHO Department of Sexual and Reproductive Health and Research (SRH) has developed target product profiles (TPPs), a form of technical guidance, for these STI diagnostics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>SRH conducted a survey of selected companies that are developing POCTs for one or more of the STIs mentioned above to better understand how these TPPs influence the diagnostic development process \u2013 to assess their impact.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Survey respondents indicated that the STI POCT\u00a0TPPs provided good guidance with respect to performance expectations and operational characteristics for the tests\/platforms. In particular, optimal metrics for sensitivity, specificity, sample types, and time to result were considered to be very useful.<\/jats:p>\n                <jats:p>Respondents also suggested ways to improve the relevance of the STI POCT\u00a0TPPs. For example, since it is often not possible for developers to achieve every desired standard, it would be useful to prioritize each performance\/operational characteristic of the test and to provide a rationale as to why certain characteristics are considered important.<\/jats:p>\n                <jats:p>Respondents also emphasized the need to encourage industry participation in the TPP development process and to find creative ways, including via targeted emails, a WHO webpage directed at industry, or a coordinated communications plan to increase awareness of the TPPs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Companies value the STI\u00a0POCT TPPs and want them to continue. In order to maximize impact, WHO should consider the proposals from the manufacturers in the interest of increasing and accelerating access to STI diagnostics and treatment in low-resource settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13690-021-00708-y","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T04:03:04Z","timestamp":1635307384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The relevance of target product profiles for manufacturers, experiences from the World Health Organization initiative for point-of-care testing for sexually transmitted infections"],"prefix":"10.1186","volume":"79","author":[{"given":"Maurine","family":"Murtagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-9124","authenticated-orcid":false,"given":"Karel","family":"Blondeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-8873","authenticated-orcid":false,"given":"Rosanna W.","family":"Peeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-7858","authenticated-orcid":false,"given":"James","family":"Kiarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-7368","authenticated-orcid":false,"given":"Igor","family":"Toskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"8","key":"708_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548\u2013562P. https:\/\/doi.org\/10.2471\/BLT.18.228486 Epub 2019 Jun 6. PMID: 31384073; PMCID: PMC6653813.","journal-title":"Bull World Health Organ"},{"issue":"8","key":"708_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S1473-3099(19)30296-8","volume":"19","author":"U Wieland","year":"2019","unstructured":"Wieland U, Kreuter A. Anal cancer risk: HPV-based cervical screening programmes. Lancet Infect Dis. 2019;19(8):799\u2013800. https:\/\/doi.org\/10.1016\/S1473-3099(19)30296-8 Epub 2019 Jun 13. PMID: 31204305.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"708_CR3","doi-asserted-by":"publisher","first-page":"e0211720","DOI":"10.1371\/journal.pone.0211720","volume":"14","author":"EL Korenromp","year":"2019","unstructured":"Korenromp EL, Rowley J, Alonso M, Mello MB, Wijesooriya NS, Mahian\u00e9 SG, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One. 2019;14(2):e0211720. https:\/\/doi.org\/10.1371\/journal.pone.0211720 Erratum in: PLoS One. 2019 Jul 5;14(7):e0219613. PMID: 30811406; PMCID: PMC6392238.","journal-title":"PLoS One"},{"key":"708_CR4","volume-title":"Global health sector strategy on sexually transmitted infections 2016-2021","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global health sector strategy on sexually transmitted infections 2016-2021. Geneva: WHO; 2016."},{"issue":"11","key":"708_CR5","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.3201\/eid1011.040622_02","volume":"10","author":"C Deal","year":"2004","unstructured":"Deal C, Cates W, Peeling R, Wald A. Long-term clinical sequelae of sexually transmitted infections in women. Emerg Infect Dis. 2004;10(11):e2. https:\/\/doi.org\/10.3201\/eid1011.040622_02.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"708_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2016.08.008","volume":"216","author":"DG Tsevat","year":"2017","unstructured":"Tsevat DG, Wiesenfeld HC, Parks C, Peipert JF. Sexually transmitted diseases and infertility. Am J Obstet Gynecol. 2017;216(1):1\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2016.08.008 PMID: 28007229; PMCID: PMC5193130.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"708_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/sextrans-2019-054358","volume":"96","author":"I Toskin","year":"2020","unstructured":"Toskin I, Govender V, Blondeel K, Murtagh M, Unemo M, Zemouri C, et al. Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections. Sex Transm Infect. 2020;96(5):342\u20137. https:\/\/doi.org\/10.1136\/sextrans-2019-054358 Epub 2020 Apr 2. PMID: 32241905; PMCID: PMC7402556.","journal-title":"Sex Transm Infect"},{"issue":"Suppl 6","key":"708_CR8","doi-asserted-by":"publisher","first-page":"e25343","DOI":"10.1002\/jia2.25343","volume":"22","author":"TE Wi","year":"2019","unstructured":"Wi TE, Ndowa FJ, Ferreyra C, Kelly-Cirino C, Taylor MM, Toskin I, et al. Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward. J Int AIDS Soc. 2019;22(Suppl 6):e25343. https:\/\/doi.org\/10.1002\/jia2.25343 PMID: 31468679; PMCID: PMC6715950.","journal-title":"J Int AIDS Soc"},{"key":"708_CR9","unstructured":"World Health Organization. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people. Recommendations for a public health approach: WHO; 2011. Available at:\u00a0https:\/\/apps.who.int\/iris\/handle\/10665\/44619. Accessed 22 Oct 2021."},{"issue":"1","key":"708_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41564-018-0295-3","volume":"4","author":"KJ Land","year":"2019","unstructured":"Land KJ, Boeras DI, Chen XS, Ramsay AR, Peeling RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol. 2019;4(1):46\u201354. https:\/\/doi.org\/10.1038\/s41564-018-0295-3 Epub 2018 Dec 13. PMID: 30546093; PMCID: PMC7097043.","journal-title":"Nat Microbiol"},{"key":"708_CR11","unstructured":"Murtagh MM. The point-of-care diagnostic landscape for sexually transmitted infections (STIs): The Murtagh Group, LLC; 2019. Available at: https:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/Diagnostic-Landscape-for-STIs-2019.pdf. Accessed 22 Oct 2021."},{"key":"708_CR12","unstructured":"World Health Organization. Target product profiles. Global observatory on health R&D. Geneva: WHO. Available at: https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/analyses-and-syntheses\/targetproduct-profile\/who-target-product-profiles. Accessed 22 Oct 2021."},{"issue":"S4","key":"708_CR13","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1136\/sextrans-2016-053071","volume":"93","author":"I Toskin","year":"2017","unstructured":"Toskin I, Murtagh M, Peeling RW, Blondeel K, Cordero J, Kiarie J. Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis. Sex Transm Infect. 2017;93(S4):S69\u201380. https:\/\/doi.org\/10.1136\/sextrans-2016-053071 PMID: 29223965.","journal-title":"Sex Transm Infect"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-021-00708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-021-00708-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-021-00708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T16:06:45Z","timestamp":1635350805000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-021-00708-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s13690-021-00708-y","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}